Articles

Breakthrough Seizures—Approach to Prevention and Diagnosis

What causes breakthrough seizures?There are a number of potential causes of the unexpected occurrence of a breakthrough seizure. One important factor...

Current Developments in Epilepsy Treatment

First Seizure and New Onset EpilepsyWhen a patient has suffered the first epileptic seizure, a decision whether to treat or not is based on the risk...

Deep Brain Stimulation

However, at this time, many questions are still unanswered and many options are still debated. What is the appropriate structure to stimulate or to...

Depression in Epilepsy Mechanisms and Therapeutic Approaches

Epilepsy and Depression – A Bi-directional RelationshipAssessing the prevalence of depression from selected clinical samples of patients with...

Epilepsy Management - Key Issues, Challenges, and Developments

Therapy of epilepsy is based on a correct diagnosis of the epilepsy syndrome, appropriate choice of medication(s), early identification of medically...

Initial Therapy for Epilepsy A Focus on Pre-menopausal Women

Women present a special complexity in terms of tolerability because there are several issues to consider and the weighting of these issues may change...

Medication-taking Behavior of Patients with Epilepsy

The concept of compliance is important because negative outcomes such as increased seizure frequency, increased hospital admissions, loss of driving...

Modern Approaches to Epilepsy Management

His research interests include antiepileptic drug neuropharmacology, the management of epilepsy and factors affecting outcome, which has resulted in...

New Add-on Therapy for Partial-onset Epilepsy

The ideal medical management of epilepsy is based on tailoring each patient’s regimen to his or her seizure type, comorbidities, lifestyle, and...

Pharmacological Treatment of Status Epilepticus - An Overview

Although every seizure type can theoretically persist and evolve into SE, a simple 2D SE classification system can be constructed, either generalized...

Recent Advances in the Neurochemistry of Epilepsy

Epilepsy is a common neurological disorder, affecting 1–2% of the population worldwide, and is characterised by recurrent spontaneous seizures....

Retigabine A Promising New Antiepileptic Drug with a Novel Mechanism of Action

Depending on the pattern of neuronal involvement, the symptomatology (or semiology) of a seizure may consist of a wide range of sudden and transitory...

Shocking the Wandering Nerve Vagus Nerve Stimulation After a Decade of Widespread Use

VNS has become an invaluable tool in the treatment of refractory epilepsy. It is cost-effective3-6 and has been shown to reduce the number of...

Shocking the Wandering Nerve Vagus Nerve Stimulation After a Decade of Widespread Use

Proposed Mechanisms of Vagus Nerve StimulationThe mechanism by which VNS exerts its effect has not been fully elucidated.However, several studies...

The Need for Broad Spectrum and Safe Anti-epileptic Drugs in Childhood Epilepsy

Only in a few situations is the best choice not to start treatment. For instance, in benign rolandic epilepsy with only nightly, partial seizures...

The Role of Vagus Nerve Stimulation in the Treatment of Epilepsy

Following the first encouraging human trials in 1988, 1,2 several controlled studies have demonstrated the antiepileptic efficacy of adjunctive vagus...

The Top Five Advances in the Use of Ketogenic Diets for Epilepsy and Beyond

How has the KD changed from an unproven, ‘alternative’ epilepsy treatment to an established, non-pharmacological medical therapy over the...

Topiramate and its Use in the Therapy of Epilepsy in the Elderly

The symptomatic focal epilepsy is the most frequently diagnosed type. Main causes are strokes 6,7 followed by brain tumours4 and degenerative...

Topiramate in the Treatment of Epilepsy - A Review

Mechanism of Action of Topiramate Although the exact mechanism of action of TPM remains unknown, multiple mechanisms have been hypothesised based on...

Updates on Epilepsy Treatment with Levetiracetam

Several new AEDs—felbamate, gabapentin, lamotrigine, levetiracetam (LEV), oxcarbazepine, tiagabine, topiramate, vigabatrin, zonisamide, and...

Copyright® 2012 Touch Group PLC. All rights reserved.
Touch Neurology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.